116 related articles for article (PubMed ID: 6379784)
1. [Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer].
Decroix G; Chastang C; Lebeau B; Fabre C; Lepage T; Rebishung JL; Babo P; Fichet D; Soubrane C; Asselain B
Rev Mal Respir; 1984; 1(1):25-30. PubMed ID: 6379784
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
Wagner W; von Eiff M; Klinke F; Micke O; Rübe C; Willich N
Strahlenther Onkol; 1995 Jul; 171(7):390-7. PubMed ID: 7631260
[TBL] [Abstract][Full Text] [Related]
4. Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group.
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):842-7. PubMed ID: 2860271
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
7. [Survival of patients with planocellular bronchial carcinoma who were treated conservatively and with surgery].
Nagorni-Obradović L
Med Pregl; 1993; 46(11-12):429-33. PubMed ID: 7997199
[TBL] [Abstract][Full Text] [Related]
8. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
Fujisawa T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
[TBL] [Abstract][Full Text] [Related]
9. [What is safe in the therapy of non-small cell bronchial cancer?].
Gropp C
Internist (Berl); 1984 Dec; 25(12):747-51. PubMed ID: 6097563
[No Abstract] [Full Text] [Related]
10. [Effect of adjuvant immunotherapy with Nocardia rubra cell-wall skeleton in lung cancer].
Yasumoto K; Ichinose Y; Yaita H; Tanaka K; Hara N; Ohta M; Hirota N; Nomoto K; Inokuchi K; Yamamura Y
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):321-7. PubMed ID: 6325864
[TBL] [Abstract][Full Text] [Related]
11. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
Kimura H; Yamaguchi Y
Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
[TBL] [Abstract][Full Text] [Related]
12. Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma.
Fujisawa T; Yamaguchi Y
Cancer; 1996 Nov; 78(9):1892-8. PubMed ID: 8909308
[TBL] [Abstract][Full Text] [Related]
13. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
Weitberg AB; Liu L; Yashar J; Glicksman AS
J Exp Clin Cancer Res; 2001 Sep; 20(3):335-40. PubMed ID: 11718211
[TBL] [Abstract][Full Text] [Related]
14. [Combined therapy for stage IIIa non-small cell lung cancer].
Zhao LQ; Hou SC; Li H; Hu B; Wang Y
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2030-2. PubMed ID: 16313794
[TBL] [Abstract][Full Text] [Related]
15. [Role of immunotherapy in the combined treatment of lung cancer].
Trapeznikov NN; Gorodilova VV; Babakova SV; Kadagidze ZG; Trakhtenberg AKh
Vopr Onkol; 1982; 28(2):51-6. PubMed ID: 6278769
[No Abstract] [Full Text] [Related]
16. [Immunotherapy of resectable lung cancer using Nocardia rubra cell wall skeleton].
Ogura T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):366-72. PubMed ID: 6349535
[TBL] [Abstract][Full Text] [Related]
17. Postoperative nonspecific immunotherapy in primary bronchogenic carcinoma.
Djurovic V; Decroix G
Recent Results Cancer Res; 1977; (62):156-63. PubMed ID: 203002
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant systemic therapy of lung cancer.
Muggia FM; McGuire WP
Cancer Clin Trials; 1978; 1(3):235-41. PubMed ID: 229981
[TBL] [Abstract][Full Text] [Related]
19. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
20. Optimal treatment for localized esophageal cancer still uncertain.
Lord RV
Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
